Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)

NCT06981637 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
81
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

National Health Research Institutes, Taiwan

Collaborators